HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity
Launched by RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY · Mar 14, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The HomeStyles-2 trial is studying how parents can help prevent obesity in their children aged 6 to 11 years by creating a healthier home environment. The program focuses on teaching parents how to improve their family's eating habits, physical activity, and sleep patterns. By participating, families will be divided into two groups: one will receive the HomeStyles intervention, which is designed to encourage healthy lifestyle changes, while the other group will take part in a different program that does not focus on obesity but provides similar support.
To join the study, parents need to be between 24 and 50 years old, have at least one child aged 6 to 11, and actively participate in making food choices for their family. They should also have regular internet access and be able to read English or Spanish. Throughout the study, participants will share information about their family's health and habits, helping researchers understand how effective the program is in promoting a healthier lifestyle. This is a great opportunity for families to learn together and contribute to important research that can help combat childhood obesity.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • parent between the ages of 24 and 50 years with at least 1 child aged 6 to 11 years; primary food gatekeeper in the household (i.e., makes all or most decisions related to family food choices), have regular Internet access, read English and/or Spanish, and reside in the United States
- Exclusion Criteria:
- • Does not fit inclusion criteria
About Rutgers, The State University Of New Jersey
Rutgers, The State University of New Jersey, is a prestigious public research university renowned for its commitment to advancing medical science and public health. As a leading clinical trial sponsor, Rutgers leverages its extensive academic resources, cutting-edge facilities, and a diverse team of experts to conduct innovative research that addresses critical health challenges. The university fosters collaboration across disciplines, engaging in partnerships with healthcare institutions and industry leaders to enhance the development of novel therapies and improve patient outcomes. With a strong emphasis on ethical standards and regulatory compliance, Rutgers is dedicated to advancing clinical knowledge while prioritizing participant safety and well-being in all of its research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Brunswick, New Jersey, United States
Patients applied
Trial Officials
Carol Byrd-Bredbenner, PhD
Principal Investigator
Rutgers Universitiy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials